Moreover, because JQ1 also inhibits BRD2, BRD3, and other BET family members, in the future it will be important to test the extent to which BET family members contribute to JQ1 anti-tumor activity in HCC and other cancers [4, 32]. This evidence concerns the gene DNER and hepatocellular carcinoma.